Aortyx logo — The Ultimate Solution for Aortic Diseases

Aortyx

The Ultimate Solution for Aortic Diseases

Founded 2018 Spain Spain 20 employees Series A Total: $21.32M Biotechnology, Life Sciences

General Information

Company Name Aortyx
Founded Year 2018
Location Spain Spain
Employees 20
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Aortyx. To contact Aortyx, visit aortyx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Aortyx

Aortyx is a pioneering company in the biotechnology and life sciences industries, with a focus on developing innovative medical devices for vascular repair. The company, founded in 2018 in Spain, is driven by the mission to provide the most advanced technology and treatments for patients with aortic diseases. Aortyx has spun off from the IQS School of Engineering and Hospital Clínic de Barcelona, leveraging expertise from these institutions. The company recently received a substantial investment of €2.50M in the form of a grant from the European Innovation Council on 17 December 2021. This investment signifies a vote of confidence in Aortyx's potential to address unmet medical needs in the field of vascular repair. With its compelling slogan, "The Ultimate Solution for Aortic Diseases," Aortyx demonstrates its commitment to delivering cutting-edge solutions in the healthcare industry.

Taxonomy: aortic dissection, minimally invasive treatment, aortic diseases, clinical settings, non-invasive solutions, medical professionals, scientists, engineers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €13.80M 7
CDTI, Ship2B Ventures +5
12 Jun 2025
Grant €2.50M 1
European Innovation Council
17 Dec 2021
Equity Crowdfunding $2.40M 1
Capital Cell
26 Apr 2021
Seed Round $1.90M 1
Capital Cell
08 Apr 2021
Seed Round $722.00K 1
Capital Cell
31 Mar 2020

Aortyx Alternatives & Competitors

View All Alternatives
Aortyx vs
Epion Therapeutics
Epion Therapeutics United States

A clinical-stage company developing a minimally-invasive treatment for keratoconus

Series A
12 employees
Biotechnology, Health Care
Aortyx vs

Brain interfaces for better health: Scientifically grounded. Technically ambitious.

11 employees
Biotechnology, Health Care
Aortyx vs

Developing a disease-modifying regenerative therapy for degenerative disc disease

5 employees
Biotechnology, Health Care

FAQ About Aortyx

The Ultimate Solution for Aortic Diseases
Aortyx was founded in 2018.
Aortyx is headquartered in Spain.
Aortyx operates in Biotechnology and Life Sciences. Its work centres on aortic dissection, minimally invasive treatment, aortic diseases and clinical settings.
Aortyx has approximately 20 employees.
Aortyx has completed 5 funding rounds, raising a total of $21.32M. The latest funding stage is Series A.
Top alternatives and competitors to Aortyx include Epion Therapeutics, Starfish Neuroscience, Notogen Inc., HepQuant, LLC, iVeena. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aortyx and Epion Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aortyx, https://bouncewatch.com/company/aortyx, updated 12 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes